Capital World Investors’s DexCom DXCM Stock Holding History

Capital World Investors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,384,000	Closed	-$86.9M	–	655
2026 Q1	$86.9M	Hold	1,384,000	–	–	0.01%	400
2025 Q4	$91.9M	Hold	1,384,000	–	–	0.01%	360
2025 Q3	$93.1M	Sell	1,384,000 -2,924	-0.2%	-$231K	0.01%	352
2025 Q2	$121M	Sell	1,386,924 -1,686,334	-55%	-$132M	0.02%	329
2025 Q1	$210M	Sell	3,073,258 -769,362	-20%	-$62.8M	0.03%	266
2024 Q4	$299M	Sell	3,842,620 -3,785,016	-50%	-$280M	0.05%	245
2024 Q3	$511M	Sell	7,627,636 -682,371	-8%	-$56M	0.08%	189
2024 Q2	$942M	Buy	8,310,007 +237,877	+3%	+$30.1M	0.15%	137
2024 Q1	$1.12B	Sell	8,072,130 -1,206,555	-13%	-$152M	0.19%	123
2023 Q4	$1.15B	Buy	9,278,685 +5,256,092	+131%	+$537M	0.2%	120
2023 Q3	$375M	Buy	4,022,593 +152,026	+4%	+$17.1M	0.07%	222
2023 Q2	$497M	Buy	3,870,567 +124,197	+3%	+$15M	0.1%	194
2023 Q1	$435M	Sell	3,746,370 -89,032	-2%	-$9.97M	0.09%	199
2022 Q4	$434M	Buy	3,835,402 +69,173	+2%	+$7.59M	0.09%	194
2022 Q3	$303M	Buy	3,766,229 +47,344	+1%	+$4.01M	0.07%	229
2022 Q2	$277M	Buy	3,718,885 +95,145	+3%	+$8.68M	0.06%	241
2022 Q1	$463M	Sell	3,623,740 -1,924,032	-35%	-$210M	0.08%	213
2021 Q4	$745M	Sell	5,547,772 -479,464	-8%	-$68.9M	0.12%	171
2021 Q3	$824M	Sell	6,027,236 -792	-0%	-$99.9K	0.14%	162
2021 Q2	$643M	Buy	6,028,028 +775,804	+15%	+$74.5M	0.11%	184
2021 Q1	$472M	Buy	5,252,224 +8	+0%	+$751	0.09%	203
2020 Q4	$485M	Sell	5,252,216 -1,780,448	-25%	-$159M	0.09%	198
2020 Q3	$725M	Sell	7,032,664 -94,436	-1%	-$9.87M	0.16%	135
2020 Q2	$722M	Buy	7,127,100 +926,848	+15%	+$82.9M	0.17%	129
2020 Q1	$417M	Sell	6,200,252 -6,618,136	-52%	-$412M	0.12%	147
2019 Q4	$701M	Sell	12,818,388 -3,589,216	-22%	-$170M	0.16%	142
2019 Q3	$612M	Sell	16,407,604 -86,660	-0.5%	-$3.37M	0.15%	147
2019 Q2	$618M	Buy	16,494,264 +3,730,264	+29%	+$117M	0.14%	144
2019 Q1	$380M	Buy	12,764,000 +8,296,000	+186%	+$292M	0.09%	181
2018 Q4	$134M	Buy	4,468,000 +640,000	+17%	+$20.3M	0.04%	261
2018 Q3	$137M	Sell	3,828,000 -16,872,000	-82%	-$523M	0.03%	272
2018 Q2	$492M	Sell	20,700,000 -352,000	-2%	-$7.46M	0.11%	168
2018 Q1	$390M	Buy	21,052,000 +7,440,000	+55%	+$110M	0.09%	191
2017 Q4	$195M	Buy	+13,612,000	New	+$177M	0.04%	237
2017 Q1	–	Sell	-524,000	Closed	-$7.82M	–	499
2016 Q4	$7.82M	Hold	524,000	–	–	﹤0.01%	459
2016 Q3	$11.5M	Hold	524,000	–	–	﹤0.01%	438
2016 Q2	$10.4M	Buy	+524,000	New	+$8.92M	﹤0.01%	435

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Capital World Investors's DXCM Position: Q2 2026 in Review

Capital World Investors sold out of DexCom (DXCM) in Q2 2026, closing a stake of 1,384,000 shares — an estimated $86.9M sold.

Capital World Investors first reported a position in DXCM in Q2 2016 and held it in 37 quarters. The position peaked at $1.15B in Q4 2023. 758 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Capital World Investors reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Capital World Investors sold 1,384,000 DexCom shares in Q2 2026, an estimated $86.9M.
Capital World Investors first reported a position in DexCom in Q2 2016 and held it in 37 quarters.
Capital World Investors's DexCom position peaked at $1.15B in Q4 2023.
758 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.